Research indicates that curcumin inhibits the migration and invasion of cancer cells by suppressing matrix metalloproteinases (MMP-2) and (MMP-9), which are enzymes that facilitate cancer spread by degrading the extracellular matrix (525, 526)
Emerging studies suggest GLP-1 agonists may reduce inflammatory markers and cytokines involved in rheumatoid arthritis through direct immune modulation and weight-loss-related benefits
Clinical validation holds equal importance
Taylor Foreman, National Institutes of Health (NIH), United States Updates Copyright 2021 To, Cao, Yegiazaryan, Owens, Nguyen, Sasaninia, Vaughn, Singh, Truong, Medina, Avitia, Villegas, Pham, Sathananthan and Venketaraman
Semaglutide, Ozempic and Wegovy Semaglutide is the active ingredient in both Ozempic and Wegovy Ozempic is approved to treat type 2 diabetes Wegovy contains higher doses of semaglutide and is approved specifically for weight loss Other GLP-1 Options Liraglutide (Saxenda) is a daily injection approved for weight loss Tirzepatide (Zepbound, Mounjaro) is a newer medication that targets two hormones (GLP-1 and GIP) and has shown even greater weight loss in clinical trials
Participants also experienced better insulin sensitivity, reduced inflammation, improved muscle strength, faster gait speed, and enhanced cognitive performance
